MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT03489525 · COMPLETED

Trial details

NCT number: NCT03489525
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2018-05-08
Primary completion: 2022-03-21
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.